News on bioinformatics, software, genome analysis, variant classification, and IT in genetics, genomics, and molecular diagnostics.
Barrow Neurological Institute and the University of Utah will use Datavant technology to link known mutations to phenotypes in the disease registry.
C2i said that the acquisition would help it commercialize its MRDetect cancer monitoring platform as a reimbursable laboratory-developed test.
With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.
At AGBT, UCSC's Karen Miga provided updates on the human pangenome reference project and the telomere-to-telomere consortium's genome assembly work.
AMP AD 2.0 will look to bring precision medicine technologies to Alzheimer's biomarker and target discovery over the next five year.
